Investor presentationAug 2026
Aug 2026 · PPT
Source: Bse
Laxmi Organic Industries Limited (LXCHEM)
Micro CapChemicals stocks · Micro cap · NSE
Laxmi Organic Industries Ltd. is a leading Indian chemical company with 50+ products, 700+ active customers, and 4 manufacturing sites, serving 55+ countries. It operates in Essentials (e.g., Ethyl Acetate, Acetic Anhydride) and Specialties (e.g., Ketene/Diketene, Fluorination) segments, emphasizing R&D and sustainable practices.
Data qualityFresh enough for analysisQuote updated 21 Oct, 11:47 am ISTDetails
Quote21 Oct, 11:47 am IST
Base fundamentals14 Oct 2026 · screener
Latest result30 Jul, 02:19 am IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens
Trend score and candlestick chart
55NeutralSMA20 +4.5% / mo · MACD − · sector -4.2pp vs Nifty 500 (3M)
Stock trend: 61
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%
Chemicals FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
LXCHEMD candles · FIT view+8.4%TODAY · PROVISIONALLatest price ₹163.12 on 2026-10-21
Today's candle is provisional from the latest intraday quote; completed-candle scans remain unchanged.
Bar
-4.7%
RSI
40
MACD hist
-1.98
52W pos
55%
2026-10-21O ₹171.20H ₹172.66L ₹161.94C ₹163.12Vol 9.0L shIntraday candle
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
LXCHEMNifty ChemicalsNifty 500
- LXCHEM
- -3.1%
- Nifty 500
- -5.6%
- Nifty Chemicals
- -8.5%
- Vs Nifty 500
- +2.5 pp
Chart stats
19 Oct 2026- From 52W high
- -18.1%
- 52W range position
- 63%
- ATR (14)
- 5.0%
- Volume vs 20D
- 0.69x
- Avg traded value
- ₹26.5 Cr
- 20D price channel
- ₹170.1 - ₹193.8
₹209
₹107.6 - ₹209
₹8.5
Latest completed session
20-session average
55.8% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED26
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Excellent100
Revenue +39.7% · PAT +223.8% YoY
Technical
Neutral55
Price trend and sector-relative-strength timing.
Valuation
Legacy model-789.4%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence63
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +40% YoY · PAT +224% YoY · margin expansion · +32% QoQ · operating leverage
Filed 29 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹968 Cr | +39.7% | +31.7% |
| EBITDA | ₹114 Cr | +267.7% | +111.1% |
| Operating margin | 12.0% | +760 bps | +500 bps |
| PAT | ₹68 Cr | +223.8% | +209.1% |
| PAT margin | 7.0% | +399 bps | +403 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 38.90
- P/B
- 2.46
- EV/EBITDA
- 16.17
- Market Cap
- 4889.00Cr
Profitability
- ROE
- 4.11%
- ROCE
- 4.72%
- ROA
- 3.66%
- Dividend Y
- 0.17%
Growth (CAGR)
- Revenue 5Y
- 10.00%
- EPS 5Y
- -9.00%
- Revenue 3Y
- 1.00%
- EPS 3Y
- -14.00%
Balance Sheet
- Debt/Equity
- 0.28
- Interest Coverage
- 12.14×
- Altman Z
- 4.01
- Book Value
- 71.60
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 6/5
- OCF
- 175.00 Cr
- EPS TTM
- 4.54
Shareholding
- Promoter Hold
- 69.34%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 68%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 968+31.7% vs prev
Net Profit
₹ CrLatest: 68.0+209.1% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term uptrend intact. RSI 40. Wait for confirmation.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 rising (~3.8% over last month) — short-term momentum positive.
- RSI(14) at 40 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 22% off 52W high · 52% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
61
RS percentile
Stage 2 UptrendEstablished S2
1M return
-4.0%
3M return
-3.1%
6M return
+18.7%
1Y return
-13.7%
RS 1D
-5
RS 20D
-4
Sector rank
#14
Industry rank
#41
Stage evidence
- Price is 6.9% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +5.1%.
50-DMA
price below
200-DMA
price above
S2 entered
04 Aug 2026
S2 age
53 trading sessions
Sector
weakening
Industry
weakening
Relative-strength line vs Nifty 500 (base 100)
261 observations
19 Oct 2026Value 85.84-3.42%
RS vs Nifty 50086
Valuation & peers
U-Score 26 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 26 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation2/30
Growth4/25
Quality0/20
Balance Sheet11/15
Cash Flow4/10
Piotroski
7/9 (+5)
Penalties
0
Raw sum
26
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
26/100 · legacy band OVERVALUED
Positive drivers
- Piotroski is strong at 7/9.
- Balance sheet contributes 11/15 to the score.
- Cash flow contributes 4/10 to the score.
Main drags
- Fair-value margin of safety is negative at -789.4%.
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Valuation is weaker at 2/30; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
38.9
PB
2.5
EV/EBITDA
16.2
ROE
4.1%
ROCE
4.7%
FCF Yield
—
Debt/Equity
0.3
MoS
-789.4%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
26
Previous: 25 (+1)
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-789.4%
Previous: -833.2%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
25
25
25
25
25
25
25
25
25
25
25
25
Factor attribution
Valuation
2+1
was 1
Modelled fair value
Graham Number
₹85.52
-90.7% MoS
Growth-justified P/E
4.0
Growth-justified Value
₹18.34
-789.4% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
REFEX
Micro
Refex Industries Limited
Retail
match 104
70
12.8
17.8%
+69%
UNDERVALUED
RAIN
Micro
Rain Industries Limited
Retail
match 103
37
14.3
0.6%
-1153%
WATCHLIST
PRAJIND
Micro
Praj Industries Limited
Retail
match 95
25
104.0
1.5%
-8169%
OVERVALUED
RENUKA
Micro
Shree Renuka Sugars Limited
Retail
match 95
14
—
—
—
OVERVALUED
TRIVENI
Micro
Triveni Engineering & Industries Limited
Retail
match 94
31
21.5
8.7%
-188%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Where growth can come from, and what can break the case
Thesis under stressReviewed 2026-06-10T07:23:52.420Z
Management commentary snapshot
Q4FY26 revenue grew 4% YoY, but PAT declined 1% YoY. For FY26, revenue declined 5% YoY, and PAT dropped 30% YoY. Adjusted EBITDA margins compressed significantly YoY for both Q4 and FY26.
While Q4FY26 showed sequential profitability improvement, full-year FY26 results indicate significant revenue and profit contraction. The company attributes Q4 revenue growth to higher price realizations, but overall margins are under pressure. Management's mention of a 'subdued chemical environment' suggests external challenges impacting performance.
Current business mix
Revenue by Segment (FY26)
Latest issuer-disclosed distribution across 2 reported categories.
Essentials75.0%
Specialties25.0%
Growth engines
Strategic Acquisitions
Foray into fluorospecialties, acquired Ketene/Diketene business, acquired know-how of pigment derivatives.
New Products
Achieving >20%+ Revenue Contribution from New Products launched in last 5 years.
Customer Centricity
Strategic shift to Customer Centric Business Approach helped gain market and increase wallet share.
Fluorine Assets
Fluorine assets started delivering revenue in FY26.
Capacity and execution
Dahej Site 4 Commissioning
CTO received for production (first phase) and commercial delivery started in Q3FY26. Chemical charging expected in Q1FY27.
Dahej Site 4 Approvals
Inorganic EC received (May 2024), Organic CTE received (June 2024), EC and Factory License received (Q1FY26).
Tailwinds
Biobased Products Readiness
Essentials strategy includes being 'Future ready for biobased products'.
Sustainability Certifications
ISCC Plus Certification audit successfully completed at Site 4 without non-conformity.
Headwinds
Subdued Chemical Environment
Company gained market share 'even during the subdued chemical environment'.
Inflationary Pressures
Disclaimer mentions 'inflationary pressures and general economic conditions affecting demand / supply and price conditions in domestic and international markets'.
Risk radar
Fiscal Policy & Competition
Disclaimer mentions 'risks and uncertainties regarding fiscal policy, competition'.
Demand/Supply & Price Conditions
Disclaimer mentions 'general economic conditions affecting demand / supply and price conditions in domestic and international markets'.
Management accountability
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Analyst reading lens
Compare BOTH
YoY comparison is crucial to assess annual performance and account for seasonality in the chemical industry. QoQ comparison is important to track sequential momentum, especially given the stated 'improvement in Profitability on sequential basis' in Q4FY26.
Sector KPIs management disclosed
Gross Margin
Q4FY26 Gross Margin 33.6% (-100 bps YoY), FY26 Gross Margin 32.9% (-190 bps YoY).
Revenue Growth Driver
Q4FY26 revenue growth 'mainly driven by higher price realizations'.
Market Share (Essentials)
Management aims to 'Retain India market share' and 'Grow exports'.
Cost Leadership (Essentials)
Achieved through 'Raw Material, logistics' and 'Operational efficiencies'.
Management forward view
Strategic Shift
Pivoted for the next growth phase with a strategic shift to a customer-centric business approach.
Essentials Strategy
Grow in existing products, enter new products, retain India market share, grow exports, focus on operational efficiencies.
Specialties Strategy
Expand & optimize incumbents, enter new products, grow market share, focus on global customers, improve cost leadership.
New Product Sales Target
Aim to have minimum 20% sales from new products in Specialties.
Thesis monitor
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Specialties Revenue Growth | -18% YoY in FY26 | Recovery and growth in Specialties segment, especially from new products and fluorine assets. |
| EBITDA Margin | FY26 EBITDA Margin 6.0% (-330 bps YoY) | Improvement in EBITDA margins, indicating better cost control and pricing power. |
| Dahej Capacity Ramp-up | CTO received, commercial delivery started Q3FY26, chemical charging Q1FY27 | Timely commissioning and utilization ramp-up of Dahej facilities. |
| New Product Contribution | >20% revenue from new products (last 5 years) | Continued strong contribution from new products, especially in Specialties. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust Score
63Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 38th percentile of the scored universe and 23rd percentile within Chemicals. Main check: financial discipline is weak at 30/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
90 docs text-extracted · 35 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
38th percentile
overall median 67 · Chemicals: 23rd pctile, median 73 · Micro: 21st pctile, median 73
Evidence depth
Financial-only
90 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
30
weak · capital discipline
Results
34
weak · quarterly consistency
Trust positives
- ▸Promoter holding is 69.3%.
- ▸Promoter pledge is zero.
- ▸6 years of positive FCF.
Trust risks
- ▸ROCE is low at 4.7%.
- ▸ROE is low at 4.1%.
- ▸ROCE trend is -2.9%.
- ▸1/4 latest quarters had positive YoY PAT growth.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Laxmi Organic Industries Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Concall transcriptAug 2026
Aug 2026 · Transcript
Source: Bse
Annual reportAug 2026
Aug 2026 · General Update Under Reg 36(1)(B) 14 Jul - 37th AGM scheduled for August 5, 2026; annual report 2025-26 web-link shared.
Source: Bse
AnnouncementJul 2026
Jul 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 1d - Q1 FY27 earnings conference call scheduled for July 30, 2026 at 2:00 PM IST.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Jul - Laxmi Organic Industries has informed about copy of newspaper publication with respect to the Notice of 37th Annual General Meeting to be held on August …
Source: Bse
AnnouncementJun 2026
Jun 2026 · Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jul - Laxmi Organic Industries Limited has Submitted copy of Newspaper Publication of the Financial Results for the Quarter ended June 30, 2026.
Source: Bse
Announcement
Announcement Under Regulation 30 Of SEBI (LODR), 2015 23 Jun - Laxmi Organic clarified no undisclosed material information behind trading volume movement.
Source: Bse
Investor presentationMay 2026
May 2026 · PPT
Source: Bse
AnnouncementQ4 2026
Q4 2026 · Compliances-Reg.24(A)-Annual Secretarial Compliance 27 May - FY26 secretarial compliance report filed; minor delays noted in two Regulation 30 disclosures and SDD updates.
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.